N. Mahassini

615 citations
63 papers · 442 indexed · h-index 9

N. Mahassini

47 papers receiving 406 citations

Peers

N. Mahassini
Comparison fields: 5 of 70
  • Complementary and alternative medicine 197
  • Toxicology 65
  • Pharmacology 94
  • Complementary and Manual Therapy 12
  • Rheumatology 58
Replace Safiyya Mohamed Ali with:
Safiyya Mohamed Ali Singapore
Kristine Jimenez Austria
Byung-Hee Lee South Korea
Jen-Hwey Chiu Taiwan
Jong‐Jae Park South Korea
Arun Sivanandam United States
Qi Zheng China
Kwong‐Leung Chan China
Tawee Laohapand Thailand
Dominique Larrey France
N. Mahassini relative to Safiyya Mohamed Ali Singapore Safiyya Mohamed Ali's profile →
Citations per field
00.5×
Safiyya Mohamed Ali · 1×
Citations per year

Countries citing papers authored by N. Mahassini

Since Specialization
Citations

This map shows the geographic impact of N. Mahassini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Mahassini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Mahassini more than expected).

Fields of papers citing papers by N. Mahassini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Mahassini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Mahassini. The network helps show where N. Mahassini may publish in the future.

Co-authorship network

The 25 scholars most cited alongside N. Mahassini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with N. Mahassini Line = papers co-authored together N. Mahassini links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20170
2 20175
3 20171
4 20140
5 201410
6 20132
7 20131
8 20132
9 201125
10 20114
11 20111
12 20118
13 20103
14 200914
15 20097
16 20080
17 20062
18 20064
19
[Gallbladder tuberculosis associated with cholelithiasis].
20036
20 20034

About N. Mahassini

N. Mahassini is a scholar working on Microbiology, Rheumatology and Oral Surgery, having authored 63 papers that have together received 442 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (11 papers), Tracheal and airway disorders (7 papers), Soft tissue tumor case studies (6 papers), Oral and Maxillofacial Pathology (6 papers), Bone Tumor Diagnosis and Treatments (6 papers), Cardiac tumors and thrombi (5 papers), Vascular Tumors and Angiosarcomas (4 papers) and Congenital Diaphragmatic Hernia Studies (4 papers). The work is most often cited by research in Complementary and alternative medicine (197 citations), Toxicology (65 citations) and Pharmacology (94 citations). N. Mahassini has collaborated with scholars based in Morocco, Kuwait and France. Frequent co-authors include Katim Alaoui, Hamid Amarouch, Yahia Cherrah, M. Hassar, Kaoutar Znati, A. Tahri, Hassan Errihani, Rhizlane Belbaraka, Mohamed Allaoui and A. Benosman. Their work appears in journals such as Phytomedicine, Annales de Chirurgie, Canadian Urological Association Journal, Journal of Gastrointestinal Cancer and Annales d Endocrinologie.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026